Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells.
about
The role of NKT cells in tumor immunityTurned on by danger: activation of CD1d-restricted invariant natural killer T cellsInvariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid ADefective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma modelOncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in miceTrial watch: Prognostic and predictive value of the immune infiltrate in cancerHuman Umbilical Vein Endothelial Cells foster conversion of CD4+CD25-Foxp3- T cells into CD4+Foxp3+ Regulatory T Cells via Transforming Growth Factor-βThe polarization of immune cells in the tumour environment by TGFbeta.Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.Innate immune cells for immunotherapy of autoimmune and cancer disorders.Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells.The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial.
P2860
Q24648939-F1AD6943-21AA-4083-AC36-E0AD2D4604A0Q26825059-4B28252E-380C-46AB-8038-5C7BF5891762Q28294740-25EA991C-1212-4FB9-A5EF-4A4A456D6176Q33622444-97BD8F56-1AB6-4BB3-B2D9-4AA7B5D825A6Q34761156-AB24D6CB-D01D-4E4B-B09D-014FAB0DDE19Q35698850-03F6AEBD-2C6A-45FC-BE03-21B0D3F44B99Q36456483-A3A7054C-6526-4794-8598-322828AAFA16Q36700213-3565FFFA-B8C2-485E-86FD-04E558DA2C28Q37454364-B539927B-2C11-4DD2-A020-BB3C4D05A60FQ39051569-91200A1C-BCF8-41E9-ACD9-279C88032E68Q48316500-A7719C46-A275-459F-9950-8C5CFD520577Q52647355-81F9E6B4-A91D-4531-8D81-B4E300EC77E4Q55094012-CF8394B0-EC20-419B-9645-0A469145A8D6Q55642051-1A21B7CA-C252-4477-8A03-A01F3E001695
P2860
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@ast
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@en
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@nl
type
label
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@ast
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@en
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@nl
prefLabel
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@ast
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@en
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@nl
P2093
P2860
P1476
Circulating myeloid dendritic ...... rofile in invariant NKT cells.
@en
P2093
Hans J J van der Vliet
Henry B Koon
Mark A Exley
Ruojie Wang
Simon C Yue
Steven P Balk
P2860
P304
P356
10.4049/JIMMUNOL.180.11.7287
P407
P577
2008-06-01T00:00:00Z